Valerie Rodriguez-garcia

Array ( [id] => 8713354 [patent_doc_number] => 08399494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => '2,5-disubstituted phenyl carboxamide orexin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 13/126620 [patent_app_country] => US [patent_app_date] => 2009-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18560 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13126620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9441135 [patent_doc_number] => 08710246 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-29 [patent_title] => 'Substituted thiophene pentamers' [patent_app_type] => utility [patent_app_number] => 13/124621 [patent_app_country] => US [patent_app_date] => 2009-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 13675 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13124621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7567994 [patent_doc_number] => 20110288057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'SALICYLIC ACID DERIVATIVES BEING FARNESYL PYROPHOSPHATE SYNTHASE ACTIVITY INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/123681 [patent_app_country] => US [patent_app_date] => 2009-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26192 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288057.pdf [firstpage_image] =>[orig_patent_app_number] => 13123681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7530486 [patent_doc_number] => 07842708 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-30 [patent_title] => 'Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors' [patent_app_type] => utility [patent_app_number] => 12/573230 [patent_app_country] => US [patent_app_date] => 2009-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 115735 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/842/07842708.pdf [firstpage_image] =>[orig_patent_app_number] => 12573230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6546927 [patent_doc_number] => 20100016383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => '4-(3,3-DIHALO-ALLYLOXY)PHENOL DERIVATIVES HAVING PESTICIDAL PROPERTIES' [patent_app_type] => utility [patent_app_number] => 12/564995 [patent_app_country] => US [patent_app_date] => 2009-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24676 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016383.pdf [firstpage_image] =>[orig_patent_app_number] => 12564995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177621 [patent_doc_number] => 20110178060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE OF SAME' [patent_app_type] => utility [patent_app_number] => 13/119743 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 93010 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20110178060.pdf [firstpage_image] =>[orig_patent_app_number] => 13119743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650949 [patent_doc_number] => 20110300218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'NOVEL SOLID STATE FORMS OF RANOLAZINE SALTS' [patent_app_type] => utility [patent_app_number] => 13/063029 [patent_app_country] => US [patent_app_date] => 2009-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11711 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 50 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300218.pdf [firstpage_image] =>[orig_patent_app_number] => 13063029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5973264 [patent_doc_number] => 20110152361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'NOVEL EPIGALLOCATECHIN GALLATE TETRAMER AND VASCULAR ENDOTHELIAL FUNCTION IMPROVING AGENT CONTAINING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/060996 [patent_app_country] => US [patent_app_date] => 2009-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5461 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152361.pdf [firstpage_image] =>[orig_patent_app_number] => 13060996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8435598 [patent_doc_number] => 08283368 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-09 [patent_title] => 'Selective ligands for the dopamine 3 (D3) receptor and methods of using the same' [patent_app_type] => utility [patent_app_number] => 13/060306 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21914 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13060306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6640111 [patent_doc_number] => 20100036136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'Maleimide Containing Ester and Sulfide Functionalities' [patent_app_type] => utility [patent_app_number] => 12/537541 [patent_app_country] => US [patent_app_date] => 2009-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6841 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20100036136.pdf [firstpage_image] =>[orig_patent_app_number] => 12537541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368605 [patent_doc_number] => 20090306164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Methods for Treating Papilloma Virus Infection' [patent_app_type] => utility [patent_app_number] => 12/534666 [patent_app_country] => US [patent_app_date] => 2009-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24387 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306164.pdf [firstpage_image] =>[orig_patent_app_number] => 12534666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7774520 [patent_doc_number] => 08119677 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Polyamides containing amino butyric acid-based building blocks' [patent_app_type] => utility [patent_app_number] => 12/534693 [patent_app_country] => US [patent_app_date] => 2009-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 24098 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119677.pdf [firstpage_image] =>[orig_patent_app_number] => 12534693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7757534 [patent_doc_number] => 20120029216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'SCALABLE SYNTHETIC PROCESS FOR MAKING TERAMEPROCOL' [patent_app_type] => utility [patent_app_number] => 13/056733 [patent_app_country] => US [patent_app_date] => 2009-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15374 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20120029216.pdf [firstpage_image] =>[orig_patent_app_number] => 13056733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6637533 [patent_doc_number] => 20100173874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Delivery of modulators of glutamate-mediated neurotransmission to the inner ear' [patent_app_type] => utility [patent_app_number] => 12/462255 [patent_app_country] => US [patent_app_date] => 2009-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13318 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173874.pdf [firstpage_image] =>[orig_patent_app_number] => 12462255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9552342 [patent_doc_number] => 08759390 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'Chromene modulators of chemokine receptor activity' [patent_app_type] => utility [patent_app_number] => 13/003777 [patent_app_country] => US [patent_app_date] => 2009-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25906 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13003777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6212294 [patent_doc_number] => 20110135594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'OXINDOLYL INHIBITOR COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/997487 [patent_app_country] => US [patent_app_date] => 2009-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12898 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135594.pdf [firstpage_image] =>[orig_patent_app_number] => 12997487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7550901 [patent_doc_number] => 08063234 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-22 [patent_title] => 'Substituted 7-sulfanylmethyl-, 7-sulfinylmethyl- and 7-sulfonylmethylindoles and the use thereof' [patent_app_type] => utility [patent_app_number] => 12/490333 [patent_app_country] => US [patent_app_date] => 2009-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 122155 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/063/08063234.pdf [firstpage_image] =>[orig_patent_app_number] => 12490333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7703043 [patent_doc_number] => 08088797 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-03 [patent_title] => 'Substituted N-(4-cyano-1H-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof' [patent_app_type] => utility [patent_app_number] => 12/490735 [patent_app_country] => US [patent_app_date] => 2009-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11021 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/088/08088797.pdf [firstpage_image] =>[orig_patent_app_number] => 12490735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177861 [patent_doc_number] => 20110178098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'ANTICANCER COMPOUNDS AND METHODS OF MAKING AND USING SAME' [patent_app_type] => utility [patent_app_number] => 12/999218 [patent_app_country] => US [patent_app_date] => 2009-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 36503 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20110178098.pdf [firstpage_image] =>[orig_patent_app_number] => 12999218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374999 [patent_doc_number] => 20090312560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'PROCESSES FOR MAKING PREGABALIN AND INTERMEDIATES THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/481173 [patent_app_country] => US [patent_app_date] => 2009-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6186 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312560.pdf [firstpage_image] =>[orig_patent_app_number] => 12481173 [rel_patent_id] =>[rel_patent_doc_number] =>)